FindTrial
Sign In

A clinical study of effect of Madhutailik Basti(medicated enema) along with antidiabetic drugs in the treatment of type 2 diabetes mellitus(Prameha).

A randomized control clinical study on the effect of Madhutailik Basti with oral hypoglycemic agents on HbA1c value in Prameha with special reference to type 2 diabetes mellitus. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/083834
Enrollment
60
Registered
2025-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Sane Guruji Arogya Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed patients of Type 2 Diabetes Mellitus. HbA1c value 6.5% or above. Age group between 30 to 60 years. Patients taking anti-diabetic drugs. Fasting blood sugar level within 150 mg/dl and Post prandial blood sugar within 250 mg/dl. Patient who is taking regular OHA(Oral Hypoglycemic agents) upto three molecules Basti Arha18

Exclusion criteria

Exclusion criteria: Patients of insulin dependent diabetes mellitus (Type I). Diabetes due to Endocrinopathies for eg. Acromegaly, Cushing syndrome. Drugs or chemical induced diabetes mellitus. Hypertension Patients with other systemic complication which may interfere in treatment. Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
To study the effect of Madhutailik Basti with Oral hypoglycemic agents on HbA1c value.Timepoint: Patients will be assessed on 0th, 7th, 37th, 67th day and follow up on 90th day.—

Secondary

MeasureTime frame
To study the effect of Madhutailik Basti with Oral hypoglycemic agents on blood glucose level. To study the effect of Madhutailik Basti with Oral hypoglycemic agents in Prameha(Type 2 diabetes mellitus).Timepoint: Patients will be assessed on 0th, 7th, 37th, 67th day and follow up on 90th day. Patients will be assessed on 0th, 7th, 37th, 67th day and follow up on 90th day.—

Countries

India

Contacts

Public ContactDr Nilima Anandrao Patekar

Sumatibhai shah Ayurveda Mahavidyalaya,Malwadi,Hadapsar,Pune

drmayagokhale@gmail.com9422323285

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026